JP TSE 4536 Pharmaceutical

Santen Pharmaceutical Co., Ltd.

参天製薬株式会社

Revenue

¥292B

≈ $1.8B

Net income

¥37.4B

≈ $236.8M

Income taxes paid

¥7.4B

≈ $47.1M

Total assets

¥423B

≈ $2.7B

Equity ratio

70.2%

Ranked #465 among listed Japanese companies by corporate taxes paid · effective tax rate 20.8%.

Share price at fiscal year-end: ¥1,790 · market capitalization ¥577B · P/E 15.7 · P/B 1.94

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥292B	¥37.4B	¥9.9B	¥7.4B	¥423B	¥297B	70.2%	EDINET (consol.)
Mar 2025	¥300B	¥36.3B	¥11.6B	¥12.2B	¥409B	¥286B	69.9%	EDINET (consol.)
Mar 2024	¥302B	¥26.6B	—	—	¥436B	¥306B	70.2%	EDINET (consol.)
Mar 2023	¥279B	−¥14.9B	—	—	¥421B	¥294B	69.8%	EDINET (consol.)
Mar 2022	¥266B	¥27.2B	—	—	¥460B	¥337B	73.4%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.